31-Dec-23 | 31-Dec-22 | 31-Dec-21 | 31-Dec-20 | 31-Dec-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Rest of World | 13,815.00 | 46% | 14,087.00 | 48% | n/a | n/a | n/a | n/a | n/a | n/a |
UK | 693.00 | 2% | 695.00 | 2% | 656.00 | 3% | 980.00 | 3% | 942.00 | 3% |
US | 15,820.00 | 52% | 14,542.00 | 50% | 11,914.00 | 48% | 14,556.00 | 43% | 13,890.00 | 41% |
Unanalysed | n/a | n/a | n/a | n/a | 12,126.00 | 49% | 18,563.00 | 54% | 18,922.00 | 56% |
Total | 30,328.00 | 100% | 29,324.00 | 100% | 24,696.00 | 100% | 34,099.00 | 100% | 33,754.00 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 6,064.00 | 100% | 5,628.00 | 100% | 3,599.00 | 100% | 6,968.00 | 100% | 6,221.00 | 100% |
Total | 6,064.00 | 100% | 5,628.00 | 100% | 3,599.00 | 100% | 6,968.00 | 100% | 6,221.00 | 100% |
31-Dec-23 | 31-Dec-22 | 31-Dec-21 | 31-Dec-20 | 31-Dec-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Commercial operations | n/a | n/a | n/a | n/a | 24,696.00 | 100% | n/a | n/a | n/a | n/a |
Consumer Healthcare | n/a | n/a | n/a | n/a | n/a | n/a | 10,033.00 | 29% | 8,995.00 | 27% |
General Medicines | 10,220.00 | 34% | 10,118.00 | 35% | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmaceuticals | n/a | n/a | n/a | n/a | n/a | n/a | 17,056.00 | 50% | 17,554.00 | 52% |
Specialty Medicines | 10,244.00 | 34% | 11,269.00 | 38% | n/a | n/a | n/a | n/a | n/a | n/a |
Unanalysed | n/a | n/a | n/a | n/a | n/a | n/a | 28.00 | n/a | 48.00 | n/a |
Vaccines | 9,864.00 | 33% | 7,937.00 | 27% | n/a | n/a | 6,982.00 | 20% | 7,157.00 | 21% |
Total | 30,328.00 | 100% | 29,324.00 | 100% | 24,696.00 | 100% | 34,099.00 | 100% | 33,754.00 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 6,064.00 | n/a | 5,628.00 | n/a | 3,599.00 | n/a | 6,968.00 | n/a | 6,221.00 | n/a |
Total | 6,064.00 | n/a | 5,628.00 | n/a | 3,599.00 | n/a | 6,968.00 | n/a | 6,221.00 | n/a |
You are here: research